Immucor president to fight bribe claims
This article was originally published in Clinica
Norcross, Georgia-based blood screening technology firm Immucor could soon see itself embroiled in a potentially long-running legal wrangle with Italian authorities. A criminal probe into suspected bribes made by several companies to Italian doctors has alleged that Dr Gioacchino De Chirico, as former head of Immucor's Italian operations, took part in payments to two doctors in order to scoop supply contracts for the company's blood processing equipment.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.